Published in

Nature Research, Nature Medicine, 5(28), p. 1097-1097, 2022

DOI: 10.1038/s41591-022-01827-x

Links

Tools

Export citation

Search in Google Scholar

Author Correction: Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy

Journal article published in 2022 by Irene Ganan-Gomez ORCID, Hui Yang, Feiyang Ma ORCID, Guillermo Montalban-Bravo, Natthakan Thongon, Valentina Marchica, Guillaume Richard-Carpentier, Kelly Chien ORCID, Ganiraju Manyam ORCID, Feng Wang, Ana Alfonso, Shuaitong Chen, Caleb Class ORCID, Rashmi Kanagal-Shamanna ORCID, Justin P. Ingram and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO